Evidence map›Paper›PMID 33034277›Full record

ArticleTechnology in cancer research & treatment

Preliminary Simulation Study of Carotid Artery and Pharyngeal Constrictor Muscle Sparing-Radiotherapy in Glottic Carcinoma.

Yurday Ozdemir, Ibrahim Acibuci, Ugur Selek, Erkan Topkan

Open access · goldAbstract read
In one paragraph

Article in Technology in cancer research & treatment. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Yurday OzdemirDepartment of Radiation Oncology, 175695Baskent University Medical Faculty, Adana, Turkey.ORCID 0000-0002-2218-2074
Ibrahim AcibuciDepartment of Radiation Oncology, 175695Baskent University Medical Faculty, Adana, Turkey.
Ugur SelekDepartment of Radiation Oncology, School of Medicine, 52979Koc University, Istanbul, Turkey.
Erkan TopkanDepartment of Radiation Oncology, 175695Baskent University Medical Faculty, Adana, Turkey.
Başkent University · TRThe University of Texas MD Anderson Cancer Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThis preliminary simulation study aimed to compare the dosimetric outcomes of carotid arteries (CAs) and pharyngeal constrictor muscle (PCM) in patients with T1N0M0 glottic carcinoma undergoing helical tomotherapy-intensity modulated radiotherapy (HT-IMRT) and 3-dimensional conformal radiotherapy (3D-CRT) plans.

methodsIn addition to the clinical target volume (CTV) which was defined as the entire larynx, the CAs and PCM of 11 glottic carcinoma patients were delineated. The CTV was uniformly expanded 5 mm to create a planning target volume (PTV) relative to the PCM and at a distance of 2 mm from the CA. The dosimetric characteristics in HT-IMRT and lateral opposed fields-based 3D-CRT plans were analyzed.

resultsMedian D

conclusionsOur present results demonstrated the feasibility of simultaneous sparing of the CAs and PCM in HT-IMRT- compared to 3D-CRT plans in glottic carcinoma patients undergoing definitive radiotherapy.

Indexed as

Radiotherapy, ConformalAdultAgedAged, 80 and overCarotid ArteriesComputer SimulationFemaleGlottisHumansLaryngeal NeoplasmsMaleMiddle AgedOrgan Sparing TreatmentsPharyngeal MusclesRadiotherapy DosageRadiotherapy, Image-Guided3D-conformal radiotherapycarotid arteriesglottic carcinomahelical-tomotherapypharyngeal constrictor muscle

Identifiers

PMID33034277
PMCPMC7549151
OpenAlexW3092154236

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.